Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Yan‑Xing Guan"'
Autor:
Jin-xiu Zhong, Yun-yuan Kong, Rong-guang Luo, Guo-jin Xia, Wen-xing He, Xue-zhong Chen, Wei-wei Tan, Qing-jie Chen, Yu-yin Huang, Yan-xing Guan
Publikováno v:
Journal of Translational Medicine, Vol 19, Iss 1, Pp 1-14 (2021)
Abstract Background Circular RNAs (circRNAs) are pivotal regulators of various human cancers and circ-ERBB2 is abnormally expressed in breast cancer cells. However, the role and mechanism of circ-ERBB2 in HER2-positive breast cancer are still unknown
Externí odkaz:
https://doaj.org/article/70f539635ee245c0bf9a15d32195a0dd
Publikováno v:
Translational Oncology, Vol 10, Iss 4, Pp 518-526 (2017)
OBJECTIVE: A micro-molecule peptide TP1623 of 99mTc-human epithelial growth factor receptor 2 (HER2) was prepared and the feasibility of using it as a HER2-positive molecular imaging agent for breast cancer was evaluated. METHODS: TP1623 was chemical
Externí odkaz:
https://doaj.org/article/36c548d3501f49d8abc94e44542ff839
Publikováno v:
Cellular Physiology and Biochemistry, Vol 38, Iss 2, Pp 763-776 (2016)
Background/Aims: The function of BRAF V600E as a prognostic biomarker continues controversial by reason of conflicting results in the published articles. Methods: A systematical literature search for relevant articles was performed in PubMed, Cochran
Externí odkaz:
https://doaj.org/article/08c3eabba3bc4890a0e97fab6c076be8
Autor:
Xue‐Zhong Chen, Wen‐Xing He, Rong‐Guang Luo, Guo‐Jin Xia, Jin‐Xiu Zhong, Qing‐Jie Chen, Yu‐Ying Huang, Yan‐Xing Guan
Publikováno v:
Molecular Carcinogenesis. 62:532-545
Publikováno v:
Journal of Radioanalytical and Nuclear Chemistry. 331:1531-1543
Publikováno v:
Experimental and Therapeutic Medicine. 10:1013-1018
The aim of the present study was to investigate the clinical efficacy and safety of low-dose 90Sr-90Y therapy combined with the topical application of 0.5% timolol maleate solution for the treatment of superficial infantile hemangiomas (IHs). A total
Publikováno v:
Experimental and therapeutic medicine. 10(3)
The aim of the present study was to investigate the clinical efficacy and safety of low-dose 90Sr-90Y therapy combined with the topical application of 0.5% timolol maleate solution for the treatment of superficial infantile hemangiomas (IHs). A total
Publikováno v:
Experimental & Therapeutic Medicine; Sep2015, Vol. 10 Issue 3, p1013-1018, 6p